Steven Leonard Chapman - 12 Aug 2021 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
CEO AND PRESIDENT, Director
Signature
/s/ Tami Chen, Attorney-in-Fact
Issuer symbol
NTRA
Transactions as of
12 Aug 2021
Net transactions value
-$2,779,644
Form type
4
Filing time
16 Aug 2021, 20:10:18 UTC
Previous filing
07 Jul 2021
Next filing
10 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise $268 +25 +0.03% $10.73* 74,986 12 Aug 2021 Direct
transaction NTRA Common Stock Options Exercise $49,098 +5,285 +7% $9.29* 80,271 12 Aug 2021 Direct
transaction NTRA Common Stock Options Exercise $42,178 +3,242 +4% $13.01* 83,513 12 Aug 2021 Direct
transaction NTRA Common Stock Options Exercise $99,097 +7,617 +9.1% $13.01* 91,130 12 Aug 2021 Direct
transaction NTRA Common Stock Options Exercise $65,715 +3,242 +3.6% $20.27 94,372 12 Aug 2021 Direct
transaction NTRA Common Stock Options Exercise $116,352 +4,570 +4.8% $25.46 98,942 12 Aug 2021 Direct
transaction NTRA Common Stock Options Exercise $238,688 +9,375 +9.5% $25.46 108,317 12 Aug 2021 Direct
transaction NTRA Common Stock Sale $940,952 -9,294 -8.6% $101.24 99,023 12 Aug 2021 Direct F1, F2
transaction NTRA Common Stock Sale $2,450,089 -24,062 -24% $101.82 74,961 12 Aug 2021 Direct F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -25 -50% $0.000000 25 12 Aug 2021 Common Stock 25 $10.73 Direct F5
transaction NTRA Stock Option (right to buy) Options Exercise $0 -5,285 -17% $0.000000 26,652 12 Aug 2021 Common Stock 5,285 $9.29 Direct F6
transaction NTRA Stock Option (right to buy) Options Exercise $0 -3,242 -7.7% $0.000000 38,659 12 Aug 2021 Common Stock 3,242 $13.01 Direct F7
transaction NTRA Stock Option (right to buy) Options Exercise $0 -7,617 -16% $0.000000 38,867 12 Aug 2021 Common Stock 7,617 $13.01 Direct F8
transaction NTRA Stock Option (right to buy) Options Exercise $0 -3,242 -6.7% $0.000000 44,909 12 Aug 2021 Common Stock 3,242 $20.27 Direct F9
transaction NTRA Stock Option (right to buy) Options Exercise $0 -4,570 -16% $0.000000 23,320 12 Aug 2021 Common Stock 4,570 $25.46 Direct F10
transaction NTRA Stock Option (right to buy) Options Exercise $0 -9,375 -25% $0.000000 28,125 12 Aug 2021 Common Stock 9,375 $25.46 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021 as amended on May 14, 2021. The Reporting Person is subject to a Lock-up Letter Agreement that expires on September 19, 2021. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.45. to $101.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.46 to $102.28 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
F5 The option shares are fully vested and may be exercised at any time.
F6 The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
F7 The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
F8 This option vested and became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of March 9, 2021, the criteria was satisfied with respect to 31,250 additional shares.
F9 The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
F10 The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of June 3, 2021, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares.
F11 The option became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of July 1, 2021, the criteria was satisfied with respect to 18,750 additional shares.